The roles of natural triterpenoid saponins against Alzheimer's disease

The aging of the world population and increasing stress levels in life are the major cause of the increased incidence of neurological disorders. Alzheimer's disease (AD) creates a huge burden on the lives and health of individuals and has become a big concern for society. Triterpenoid saponins (TS), representative natural product components, have a wide range of pharmacological bioactivities such as anti-inflammation, antioxidation, antiapoptosis, hormone-like, and gut microbiota regulation. Notably, some natural TS exhibited promising neuroprotective activity that can intervene in AD progress, especially in the early stage. Recently, studies have indicated that TS play a pronounced positive role in the prevention and treatment of AD. This review discusses the recent research on the neuroprotection of TS and proceeds to detail the action mechanisms of TS against AD, hoping to provide a reference for drug development for anti-AD.

[1]  Lijuan Kou,et al.  Pharmacokinetics and Oral Bioavailability of Panax Notoginseng Saponins Administered to Rats Using a Validated UPLC-MS/MS Method. , 2022, Journal of agricultural and food chemistry.

[2]  Alshebli Ahmed,et al.  Alzheimer’s Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms , 2022, Molecules.

[3]  Jie Zhou,et al.  Pharmacological effects of Eleutherococcus senticosus on the neurological disorders , 2022, Phytotherapy research : PTR.

[4]  A. Ittner,et al.  Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation , 2022, Science advances.

[5]  Qiu Zhang,et al.  Gypenoside XVII, an Active Ingredient from Gynostemma Pentaphyllum, Inhibits C3aR-Associated Synaptic Pruning in Stressed Mice , 2022, Nutrients.

[6]  Qingcheng Yang,et al.  Peripheral Inflammatory Biomarkers of Alzheimer's Disease. , 2022, Journal of Alzheimer's disease : JAD.

[7]  Yi Zhang,et al.  Xanthoceraside exerts anti-Alzheimer's disease effect by remodeling gut microbiota and modulating microbial-derived metabolites level in rats. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[8]  M. Kim,et al.  Cycloastragenol, a Triterpenoid Saponin, Regulates Oxidative Stress, Neurotrophic Dysfunctions, Neuroinflammation and Apoptotic Cell Death in Neurodegenerative Conditions , 2021, Cells.

[9]  T. G. Singh,et al.  Apoptotic Pathways and Alzheimer’s Disease: Probing Therapeutic Potential , 2021, Neurochemical Research.

[10]  K. Tam,et al.  Pathological mechanisms and therapeutic strategies for Alzheimer’s disease , 2021, Neural regeneration research.

[11]  T. Pufe,et al.  Aggregated Tau-PHF6 (VQIVYK) Potentiates NLRP3 Inflammasome Expression and Autophagy in Human Microglial Cells , 2021, Cells.

[12]  Chunfu Wu,et al.  Pseudoginsenoside-F11 ameliorates okadiac acid-induced learning and memory impairment in rats via modulating protein phosphatase 2A , 2021, Mechanisms of Ageing and Development.

[13]  B. Albensi,et al.  Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia , 2021, International journal of molecular sciences.

[14]  Garam Lee,et al.  Alzheimer's disease drug development pipeline: 2021 , 2021, Alzheimer's & dementia.

[15]  S. Bardien,et al.  Can the interplay between autophagy and apoptosis be targeted as a novel therapy for Parkinson's disease? , 2020, Neurobiology of Aging.

[16]  Chunfu Wu,et al.  Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer’s disease rat model , 2020, Acta Pharmacologica Sinica.

[17]  T. G. Singh,et al.  Navigating Alzheimer's Disease via Chronic Stress: the Role of Glucucocorticoids. , 2020, Current drug targets.

[18]  Hong Yang,et al.  Protective effects of tenuifolin isolated from Polygala tenuifolia Willd roots on neuronal apoptosis and learning and memory deficits in mice with Alzheimer's disease. , 2019, Food & function.

[19]  Jingwei Tian,et al.  A 26-week 20(S)-ginsenoside Rg3 oral toxicity study in Beagle dogs. , 2019, Regulatory toxicology and pharmacology : RTP.

[20]  Haiyan Xu,et al.  Xanthoceraside Could Ameliorate Alzheimer’s Disease Symptoms of Rats by Affecting the Gut Microbiota Composition and Modulating the Endogenous Metabolite Levels , 2019, Front. Pharmacol..

[21]  Xiaomei Yang,et al.  Ginsenoside Rg3 prevents cognitive impairment by improving mitochondrial dysfunction in the rat model of Alzheimer's disease. , 2019, Journal of agricultural and food chemistry.

[22]  Daqing Zhao,et al.  Ginsenoside Re Inhibits ROS/ASK-1 Dependent Mitochondrial Apoptosis Pathway and Activation of Nrf2-Antioxidant Response in Beta-Amyloid-Challenged SH-SY5Y Cells , 2019, Molecules.

[23]  U. Dwivedi,et al.  Plant triterpenoid saponins: biosynthesis, in vitro production, and pharmacological relevance , 2019, Protoplasma.

[24]  B. Liu,et al.  High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer’s disease mice , 2019, Scientific Reports.

[25]  D. Spandidos,et al.  Panax ginseng components and the pathogenesis of Alzheimer's disease , 2019, Molecular medicine reports.

[26]  Biqiong Zhang,et al.  Ginsenoside Rg1 protects against H2O2-induced neuronal damage due to inhibition of the NLRP1 inflammasome signalling pathway in hippocampal neurons in vitro , 2018, International journal of molecular medicine.

[27]  R. Linhardt,et al.  Akebia saponin D reverses corticosterone hypersecretion in an Alzheimer's disease rat model. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[28]  Shu Liu,et al.  Study on the compatibility interactions of formula Ding‐Zhi‐Xiao‐Wan based on their main components transport characteristics across Caco‐2 monolayers model , 2018, Journal of pharmaceutical and biomedical analysis.

[29]  Xing Tang,et al.  Biopharmaceutical characters and bioavailability improving strategies of ginsenosides. , 2018, Fitoterapia.

[30]  Ping Li,et al.  Jujuboside A promotes Aβ clearance and ameliorates cognitive deficiency in Alzheimer's disease through activating Axl/HSP90/PPARγ pathway , 2018, Theranostics.

[31]  V. Shoshan-Barmatz,et al.  VDAC1, mitochondrial dysfunction, and Alzheimer's disease , 2018, Pharmacological research.

[32]  Huaxi Xu,et al.  Amyloid-beta modulates microglial responses by binding to the triggering receptor expressed on myeloid cells 2 (TREM2) , 2018, Molecular Neurodegeneration.

[33]  L. Tan,et al.  Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies. , 2018, Current Alzheimer research.

[34]  Ajay-Vikram Singh,et al.  Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer’s disease? , 2018, Journal of drug targeting.

[35]  Jaehwi Lee,et al.  Micro-/nano-sized delivery systems of ginsenosides for improved systemic bioavailability , 2018, Journal of ginseng research.

[36]  Yifa Zhou,et al.  Ginsenoside Rg2 protects PC12 cells against β-amyloid25-35-induced apoptosis via the phosphoinositide 3-kinase/Akt pathway. , 2017, Chemico-biological interactions.

[37]  Yaodong Zhang,et al.  Ginsenoside Rg1 protects against neuronal degeneration induced by chronic dexamethasone treatment by inhibiting NLRP-1 inflammasomes in mice , 2017, International journal of molecular medicine.

[38]  W. Fu,et al.  Drug candidates in clinical trials for Alzheimer’s disease , 2017, Journal of Biomedical Science.

[39]  Jian-Mei Li,et al.  Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial function , 2017, Free radical biology & medicine.

[40]  L. Ren,et al.  Astragaloside IV, a Natural PPARγ Agonist, Reduces Aβ Production in Alzheimer’s Disease Through Inhibition of BACE1 , 2017, Molecular Neurobiology.

[41]  Eugenia Trushina,et al.  Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[42]  Hong Zhang,et al.  Inhibitory Effect of Lychee Seed Saponins on Apoptosis Induced by Aβ25-35 through Regulation of the Apoptotic and NF-κB Pathways in PC12 Cells , 2017, Nutrients.

[43]  V. Préat,et al.  Pentacyclic Triterpene Bioavailability: An Overview of In Vitro and In Vivo Studies , 2017, Molecules.

[44]  J. Thornton,et al.  Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer’s disease , 2017, PLoS genetics.

[45]  Q. Mei,et al.  Lychee Seed Saponins Improve Cognitive Function and Prevent Neuronal Injury via Inhibiting Neuronal Apoptosis in a Rat Model of Alzheimer’s Disease , 2017, Nutrients.

[46]  Z. Shi,et al.  Upstream regulators and downstream effectors of NF-κB in Alzheimer's disease , 2016, Journal of the Neurological Sciences.

[47]  V. Víctor,et al.  Role of ROS and RNS Sources in Physiological and Pathological Conditions , 2016, Oxidative medicine and cellular longevity.

[48]  B. Xie,et al.  Ameliorative effect of lotus seedpod proanthocyanidins on cognitive impairment and brain aging induced by d-galactose , 2016, Experimental Gerontology.

[49]  Juliet M. Taylor,et al.  The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease , 2016, Journal of neurochemistry.

[50]  Mary Miu Yee Waye,et al.  Polygenic Analysis of Late-Onset Alzheimer’s Disease from Mainland China , 2015, PloS one.

[51]  Y. Pak,et al.  Ethanol extract of Bupleurum falcatum and saikosaponins inhibit neuroinflammation via inhibition of NF-κB. , 2015, Journal of ethnopharmacology.

[52]  Gang Zhao,et al.  Ginsenoside Rd attenuates Aβ25-35-induced oxidative stress and apoptosis in primary cultured hippocampal neurons. , 2015, Chemico-biological interactions.

[53]  Sagar H. Barage,et al.  Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease , 2015, Neuropeptides.

[54]  Y. Liu,et al.  Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer's disease mouse model: a metabolomics study. , 2015, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[55]  R. Xu,et al.  Neuroprotection by Saponins , 2015, Phytotherapy research : PTR.

[56]  D. Paik,et al.  Review of cases of patient risk associated with ginseng abuse and misuse , 2014, Journal of ginseng research.

[57]  Luc Buée,et al.  PTU‐induced hypothyroidism in rats leads to several early neuropathological signs of Alzheimer's disease in the hippocampus and spatial memory impairments , 2014, Hippocampus.

[58]  M. Obulesu,et al.  Apoptosis in Alzheimer’s Disease: An Understanding of the Physiology, Pathology and Therapeutic Avenues , 2014, Neurochemical Research.

[59]  O. Arancio,et al.  Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation , 2014, Scientific Reports.

[60]  Bing Liu,et al.  Jujuboside A, a neuroprotective agent from semen Ziziphi Spinosae ameliorates behavioral disorders of the dementia mouse model induced by Aβ 1-42. , 2014, European journal of pharmacology.

[61]  Guibo Sun,et al.  Notoginsenoside R1 attenuates amyloid-β-induced damage in neurons by inhibiting reactive oxygen species and modulating MAPK activation. , 2014, International immunopharmacology.

[62]  Y. Kitagishi,et al.  Dietary regulation of PI3K/AKT/GSK-3β pathway in Alzheimer’s disease , 2014, Alzheimer's Research & Therapy.

[63]  Guangji Wang,et al.  Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein , 2014, PloS one.

[64]  Zheying Zhang,et al.  Madecassoside prevents Aβ(25-35)-induced inflammatory responses and autophagy in neuronal cells through the class III PI3K/Beclin-1/Bcl-2 pathway. , 2014, International immunopharmacology.

[65]  Liang-Jun Yan,et al.  Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease , 2014, The International journal of neuroscience.

[66]  A. Osbourn,et al.  Triterpene biosynthesis in plants. , 2014, Annual review of plant biology.

[67]  Zhichun Chen,et al.  Oxidative stress in Alzheimer’s disease , 2014, Neuroscience Bulletin.

[68]  Jin-Lan Huang,et al.  Effects of Panax notoginseng saponin on &agr;, &bgr;, and &ggr; secretase involved in A&bgr; deposition in SAMP8 mice , 2014, Neuroreport.

[69]  J. P. de Rivero Vaccari,et al.  Pyroptotic Neuronal Cell Death Mediated by the AIM2 Inflammasome , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[70]  M. Geng,et al.  Synthesis and antitumor activities of naturally occurring oleanolic acid triterpenoid saponins and their derivatives. , 2013, European journal of medicinal chemistry.

[71]  Chunfu Wu,et al.  Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease , 2013, Pharmacology Biochemistry and Behavior.

[72]  Yu Young Lee,et al.  www.mdpi.com/journal/ijms Anti-Inflammatory Effect of Ginsenoside Rg5 in , 2013 .

[73]  Hui-li Liu,et al.  Involvement of GSK3 and PP2A in ginsenoside Rb1's attenuation of aluminum-induced tau hyperphosphorylation , 2013, Behavioural Brain Research.

[74]  J. Hort,et al.  Guest Editor: B. O. Popescu Blood markers of oxidative stress in Alzheimer’s disease , 2012 .

[75]  K. Qin,et al.  Ginsennoside Rd Attenuates Cognitive Dysfunction in a Rat Model of Alzheimer’s Disease , 2012, Neurochemical Research.

[76]  Jie Xu,et al.  Ginsenoside Rg1 promotes nonamyloidgenic cleavage of APP via estrogen receptor signaling to MAPK/ERK and PI3K/Akt. , 2012, Biochimica et biophysica acta.

[77]  J. Hyun,et al.  Anti-Inflammatory Mechanism of Compound K in Activated Microglia and Its Neuroprotective Effect on Experimental Stroke in Mice , 2012, Journal of Pharmacology and Experimental Therapeutics.

[78]  K. Qin,et al.  Protective effects of ginsenoside Rd against okadaic acid-induced neurotoxicity in vivo and in vitro. , 2011, Journal of ethnopharmacology.

[79]  Taijun Yin,et al.  Enhancement of Oral Bioavailability of 20(S)-Ginsenoside Rh2 through Improved Understanding of Its Absorption and Efflux Mechanisms , 2011, Drug Metabolism and Disposition.

[80]  D. Praticò Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. , 2008, Trends in pharmacological sciences.

[81]  N. Volkmann,et al.  Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. , 2007, Molecular cell.

[82]  J. Vincken,et al.  Saponins, classification and occurrence in the plant kingdom. , 2007, Phytochemistry.

[83]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[84]  George Perry,et al.  RNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease , 1999, The Journal of Neuroscience.

[85]  B. Hemmings Akt Signaling--Linking Membrane Events to Life and Death Decisions , 1997, Science.

[86]  Chunfu Wu,et al.  Pseudoginsenoside‐F11 alleviates cognitive deficits and Alzheimer's disease‐type pathologies in SAMP8 mice , 2019, Pharmacological research.

[87]  Feng Yang,et al.  Ginsenoside Rd promotes non‐amyloidogenic pathway of amyloid precursor protein processing by regulating phosphorylation of estrogen receptor alpha , 2017, Life sciences.

[88]  C. Behl,et al.  Apoptosis and Alzheimer's disease , 2000, Journal of Neural Transmission.